Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2009, Article ID 730739, 8 pages
http://dx.doi.org/10.1155/2009/730739
Research Article

Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues

1Department of Pathology and Cell Biology, University of South Florida, Tampa, FL 33612, USA
2Office of Clinical Research, University of South Florida, Tampa, FL 33612, USA
3H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
4Department of Oncological Sciences, University of South Florida, Tampa, FL 33612, USA

Received 17 March 2009; Revised 29 May 2009; Accepted 4 August 2009

Academic Editor: Anil K. Sood

Copyright © 2009 Christina D. Drenberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2009,” CA: A Cancer Journal for Clinicians, vol. 59, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. T. I. Williams, K. L. Toups, D. A. Saggese, K. R. Kalli, W. A. Cliby, and D. C. Muddiman, “Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers,” Journal of Proteome Research, vol. 6, pp. 2936–2962, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. J. M. J. Piek, P. Kenemans, and R. H. M. Verheijen, “Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause,” American Journal of Obstetrics and Gynecology, vol. 191, no. 3, pp. 718–732, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. L. Dubeau, “The cell of origin of ovarian epithelial tumours,” The Lancet Oncology, vol. 9, no. 12, pp. 1191–1197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Neufeld and O. Kessler, “The semaphorins: versatile regulators of tumour progression and tumour angiogenesis,” Nature Reviews Cancer, vol. 8, no. 8, pp. 632–645, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. L. Tamagnone, S. Artigiani, H. Chen et al., “Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates,” Cell, vol. 99, no. 1, pp. 71–80, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Nasarre, S. Kusy, B. Constantin et al., “Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion,” Neoplasia, vol. 7, no. 2, pp. 180–189, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. R. J. Giger, E. R. Urquhart, S. K. H. Gillespie, D. V. Levengood, D. D. Ginty, and A. L. Kolodkin, “Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity,” Neuron, vol. 21, no. 5, pp. 1079–1092, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. He and M. Tessier-Lavigne, “Neuropilin is a receptor for the axonal chemorepellent semaphorin III,” Cell, vol. 90, no. 4, pp. 739–751, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. A. L. Kolodkin, D. V. Levengood, E. G. Rowe, Y. T. Tai, R. J. Giger, and D. D. Ginty, “Neuropilin is a semaphorin III receptor,” Cell, vol. 90, no. 4, pp. 753–762, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Takahashi, F. Nakamura, Z. Jin, R. G. Kalb, and S. M. Strittmatter, “Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors,” Nature Neuroscience, vol. 1, no. 6, pp. 487–493, 1998. View at Google Scholar · View at Scopus
  12. F. Suto, Y. Murakami, F. Nakamura, Y. Goshima, and H. Fujisawa, “Identification and characterization of a novel mouse plexin, plexin-A4,” Mechanisms of Development, vol. 120, no. 3, pp. 385–396, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Takahashi and S. M. Strittmatter, “PlexinA1 autoinhibition by the plexin sema domain,” Neuron, vol. 29, no. 2, pp. 429–439, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Takahashi, A. Fournier, F. Nakamura et al., “Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors,” Cell, vol. 99, no. 1, pp. 59–69, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Soker, S. Takashima, H. Q. Miao, G. Neufeld, and M. Klagsbrun, “Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor,” Cell, vol. 92, no. 6, pp. 735–745, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Kessler, N. Shraga-Heled, T. Lange et al., “Semaphorin-3F is an inhibitor of tumor angiogenesis,” Cancer Research, vol. 64, no. 3, pp. 1008–1015, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Xiang, A. R. Davalos, C. H. Hensel, X.-J. Zhou, C. Tse, and S. L. Naylor, “Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice,” Cancer Research, vol. 62, no. 9, pp. 2637–2643, 2002. View at Google Scholar · View at Scopus
  18. D. R. Bielenberg, Y. Hida, A. Shimizu et al., “Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype,” The Journal of Clinical Investigation, vol. 114, no. 9, pp. 1260–1271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Nasarre, B. Constantin, L. Rouhaud et al., “Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading,” Neoplasia, vol. 5, no. 1, pp. 83–92, 2003. View at Google Scholar · View at Scopus
  20. S. Kusy, P. Nasarre, D. Chan et al., “Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells,” Neoplasia, vol. 7, no. 5, pp. 457–465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Brambilla, B. Constantin, H. Drabkin, and J. Roche, “Semaphorin SEMA3F localization in malignant human lung and cell lines: a suggested role in cell adhesion and cell migration,” The American Journal of Pathology, vol. 156, no. 3, pp. 939–950, 2000. View at Google Scholar
  22. S. Lantuéjoul, B. Constantin, H. Drabkin, C. Brambilla, J. Roche, and E. Brambilla, “Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines,” The Journal of Pathology, vol. 200, no. 3, pp. 336–347, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. R. Osada, A. Horiuchi, N. Kikuchi et al., “Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas,” Human Pathology, vol. 37, no. 11, pp. 1414–1425, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus